Treating Allergic Bronchopulmonary Aspergillosis: A Review
نویسندگان
چکیده
منابع مشابه
Treating allergic bronchopulmonary aspergillosis: the way forward.
Allergic bronchopulmonary mycoses are an endotype of allergic lung disease, similar to but more severe than uncomplicated asthma, caused by a Th2-dominated immune response and a bronchocentric granulocytic inflammation provoked by endobronchial growth of filamentous fungi in individuals with innate host defence defects (primarily people with severe allergic asthma or cystic fibrosis); untreated...
متن کاملAllergic bronchopulmonary aspergillosis--a clinical review.
Allergic Bronchopulmonary Aspergillosis (ABPA) was first described by Hinson and colleagues in 1952. ABPA is a hypersensitivity disorder induced by a fungus Aspergillus and affects non-immunocompromised patients. The diagnosis is based on the presence of a combination of clinical, biological and radiological criteria. The treatment is based on oral corticosteroids for 6-8 weeks at acute phase o...
متن کامل[Allergic bronchopulmonary aspergillosis].
Allergic bronchopulmonary aspergillosis (ABPA) is a syndrome seen in patients with asthma and cystic fibrosis. It is characterized by chronic colonization of the airways with a ubiquitous fungus, Aspergillus fumigatus. The clinical expression of ABPA results from the complex interaction of chronic colonization of the airways with A fumigatus, host factors allowing this colonization, and the hos...
متن کاملAllergic bronchopulmonary aspergillosis.
There remains a lack of agreement on diagnostic criteria and approaches to treatment of patients with allergic bronchopulmonary aspergillosis (ABPA). The results of a survey of American Academy of Allergy, Asthma, & Immunology members regarding these 2 issues are presented and compared for concordance with published recommendations. The literature was reviewed for pertinent reports, and an elec...
متن کاملAllergic Bronchopulmonary Aspergillosis
Allergic bronchopulmonary aspergillosis (ABPA), a progressive fungal allergic lung disease, is a common complication of asthma or cystic fibrosis. Although ABPA has been recognized since the 1950s, recent research has underscored the importance of Th2 immune deviation and granulocyte activation in its pathogenesis. There is also strong evidence of widespread under-diagnosis due to the complexit...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cureus
سال: 2019
ISSN: 2168-8184
DOI: 10.7759/cureus.4538